- Corporate Officers - A
- Aryeh Jason
Insider Trading History of Aryeh Jason
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Aryeh Jason since 2015.
This trader's CIK number is 1376960.
At the time of last reporting, Aryeh Jason was the Director of Ligand Pharmaceuticals Inc. (stock ticker symbol LGND).
Also see all insider trading activities at Ligand Pharmaceuticals Inc.
Note that in the past
Aryeh Jason also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Novelion Therapeutics Inc. (NVLN) by Aryeh Jason
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | NVLN | 361 | $3,230 | 0 | $0 | 0 | $0 |
| 2015 | NVLN | 306,400 | $1,045,268 | 0 | $0 | 70,000 | $172,750 |
Yearly summary of insider trading at Ligand Pharmaceuticals Inc (LGND) by Aryeh Jason
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LGND | 0 | $0 | 10,000 | $1,710,980 | 0 | $0 |
| 2024 | LGND | 0 | $0 | 0 | $0 | 2,406 | $125,833 |
| 2019 | LGND | 7,452 | $744,805 | 0 | $0 | 0 | $0 |
| 2018 | LGND | 0 | $0 | 38,859 | $8,607,782 | 0 | $0 |
| 2017 | LGND | 0 | $0 | 95,647 | $11,205,773 | 0 | $0 |
| 2016 | LGND | 0 | $0 | 55,938 | $6,249,575 | 0 | $0 |
| 2015 | LGND | 0 | $0 | 13,880 | $1,263,510 | 0 | $0 |
Yearly summary of insider trading at Orchestra Biomed Holdings, Inc. (OBIO) by Aryeh Jason
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | OBIO | 1,000 | $2,450 | 0 | $0 | 0 | $0 |
| 2023 | OBIO | 0 | $0 | 0 | $0 | 11,246 | $0 |
Yearly summary of insider trading at Merrimack Pharmaceuticals Inc (MACK) by Aryeh Jason
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | MACK | 3,802 | $21,474 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aralez Pharmaceuticals Inc. (ARLZ) by Aryeh Jason
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ARLZ | 295,929 | $1,732,664 | 388,685 | $558,918 | 0 | $0 |
Insider trading activities at 5 companies by Aryeh Jason:
1. Novelion Therapeutics Inc. (NVLN)
2. Ligand Pharmaceuticals Inc (LGND)
3. Orchestra Biomed Holdings, Inc. (OBIO)
4. Merrimack Pharmaceuticals Inc (MACK)
5. Aralez Pharmaceuticals Inc. (ARLZ)
Table 1. Insider trading of Novelion Therapeutics Inc. (NVLN) by Aryeh Jason
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-05-15 | NVLN | Buy | 361 | 8.95 | 3,230 |
| 2015-12-29 | QLTI | Buy | 18,400 | 2.50 | 45,908 |
| 2015-06-30 | QLTI | Option Ex | 50,000 | 3.46 | 172,750 |
| 2015-06-16 | QLTI | Buy | 288,000 | 3.47 | 999,360 |
| 2015-06-07 | QLTI | Option Ex | 20,000 | .00 | 0 |
Table 2. Insider trading of Ligand Pharmaceuticals Inc (LGND) by Aryeh Jason
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-09-23 | LGND | Sale | 10,000 | 171.10 | 1,710,980 |
| 2024-04-30 | LGND | Option Ex | 2,406 | 52.30 | 125,833 |
| 2019-09-03 | LGND | Buy | 750 | 87.01 | 65,257 |
| 2019-08-05 | LGND | Buy | 746 | 90.01 | 67,145 |
| 2019-07-30 | LGND | Buy | 3,000 | 100.22 | 300,663 |
| 2019-07-31 | LGND | Buy | 754 | 93.00 | 70,121 |
| 2019-07-29 | LGND | Buy | 250 | 106.01 | 26,502 |
| 2019-06-11 | LGND | Buy | 250 | 107.01 | 26,752 |
| 2019-05-31 | LGND | Buy | 500 | 108.51 | 54,255 |
| 2019-05-30 | LGND | Buy | 250 | 110.01 | 27,502 |
| 2019-05-29 | LGND | Buy | 250 | 111.01 | 27,752 |
| 2019-05-20 | LGND | Buy | 250 | 112.01 | 28,002 |
| 2019-05-14 | LGND | Buy | 250 | 112.51 | 28,127 |
| 2019-03-13 | LGND | Buy | 202 | 112.51 | 22,727 |
| 2018-08-17 | LGND | Sale | 26,862 | 241.81 | 6,495,553 |
| 2018-08-16 | LGND | Sale | 1,080 | 245.00 | 264,600 |
| 2018-03-09 | LGND | Sale | 4,000 | 176.47 | 705,900 |
| 2018-03-08 | LGND | Sale | 3,500 | 174.88 | 612,094 |
| 2018-02-23 | LGND | Sale | 3,417 | 155.00 | 529,635 |
| 2017-11-17 | LGND | Sale | 24,400 | 140.22 | 3,421,368 |
| 2017-08-23 | LGND | Sale | 2,000 | 127.99 | 255,980 |
| 2017-05-11 | LGND | Sale | 22,665 | 110.04 | 2,494,033 |
| 2017-05-12 | LGND | Sale | 14,582 | 111.87 | 1,631,332 |
| 2017-02-28 | LGND | Sale | 7,000 | 107.58 | 753,060 |
| 2017-02-27 | LGND | Sale | 25,000 | 106.00 | 2,650,000 |
| 2016-11-22 | LGND | Sale | 15,001 | 107.40 | 1,611,062 |
| 2016-11-25 | LGND | Sale | 3,478 | 106.96 | 372,006 |
| 2016-11-16 | LGND | Sale | 1,330 | 106.33 | 141,418 |
| 2016-11-18 | LGND | Sale | 5,000 | 105.00 | 525,000 |
| 2016-05-06 | LGND | Sale | 15,000 | 118.52 | 1,777,830 |
| 2016-05-05 | LGND | Sale | 10,000 | 120.21 | 1,202,120 |
| 2016-03-07 | LGND | Sale | 5,629 | 101.06 | 568,894 |
| 2016-03-08 | LGND | Sale | 500 | 102.49 | 51,245 |
| 2015-11-11 | LGND | Sale | 3,000 | 101.49 | 304,470 |
| 2015-06-04 | LGND | Sale | 1,640 | 92.68 | 151,995 |
| 2015-05-18 | LGND | Sale | 6,000 | 86.74 | 520,439 |
| 2015-05-19 | LGND | Sale | 2,240 | 88.82 | 198,956 |
| 2015-05-20 | LGND | Sale | 1,000 | 87.65 | 87,650 |
Table 3. Insider trading of Orchestra Biomed Holdings, Inc. (OBIO) by Aryeh Jason
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-09-19 | OBIO | Buy | 1,000 | 2.45 | 2,450 |
| 2023-04-12 | OBIO | Option Ex | 11,246 | .00 | 0 |
Table 4. Insider trading of Merrimack Pharmaceuticals Inc (MACK) by Aryeh Jason
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-07-16 | MACK | Buy | 302 | 5.44 | 1,642 |
| 2019-07-11 | MACK | Buy | 100 | 5.71 | 571 |
| 2019-07-12 | MACK | Buy | 3,400 | 5.67 | 19,261 |
Table 5. Insider trading of Aralez Pharmaceuticals Inc. (ARLZ) by Aryeh Jason
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-05-23 | ARLZ | Sale | 104,176 | 1.41 | 146,888 |
| 2017-05-19 | ARLZ | Sale | 51,041 | 1.56 | 79,572 |
| 2017-05-22 | ARLZ | Sale | 233,468 | 1.42 | 332,458 |
| 2016-09-16 | ARLZ | Buy | 295,929 | 5.86 | 1,732,664 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Aryeh Jason
(Director of Ligand Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.